Which ICS medication is listed as a mono-therapy preventer, sometimes having a brown casing?
Answer
Budesonide
Inhaled corticosteroid (ICS) medications form the backbone of single-agent (mono-therapy) controller treatments. Several specific ICS drugs are mentioned, often identifiable by distinct casing colors like brown or orange/yellow. Budesonide, for instance, is explicitly named as an ICS available as a standalone preventer (e.g., Pulmicort), alongside Beclometasone Dipropionate, Fluticasone Propionate, Ciclesonide, and Mometasone. Formoterol and Salmeterol are Long-Acting Beta Agonists (LABAs), which are bronchodilators used in combination therapy, while Tiotropium is associated with Long-Acting Muscarinic Antagonist (LAMA) therapy, used in triple therapy.
Related Questions
What is the primary goal of a preventer inhaler in long-term asthma treatment?When is adjusting preventative treatment strongly indicated for an asthma patient?Which ICS medication is listed as a mono-therapy preventer, sometimes having a brown casing?What is the most common bronchodilator paired with an Inhaled Corticosteroid (ICS) in combination inhalers?What component is added to an ICS and LABA to create a triple therapy inhaler for very severe asthma?What specific regulatory warning has been linked to the Leukotriene Modifier drug Montelukast?Approximately how long may it take for ICS therapy to manifest its maximum protective effect through consistent daily use?What key feature defines Maintenance and Reliever Therapy (MART) regarding the inhaler used?What device is highly recommended for use with Pressurised Metered Dose Inhalers (MDIs) to improve lung delivery?What is the most effective preventative measure against local side effects like oral thrush from steroid inhalers?